Tomohiro Murakawa

Prof. Tomohiro Murakawa

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2012 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
TMTomohiro Murakawa
Tomohiro Murakawa
CKChihiro Konoeda
Chihiro Konoeda
TITakuya Ito
Takuya Ito
YIYuta Inoue
Yuta Inoue
ASAtsushi Sano
Atsushi Sano
JNJun Nakajima
Jun Nakajima
The radiological ground glass opacity (GGO) component of an adenocarcinoma pathologically reflects a non-invasive adenocarcinoma in situ (AIS). Measuring the tumour diameter to include the GGO component may overestimate the T factor. In this retrospective study, we evaluated the effect of the GGO component on the recurrence of an adenocarcinoma. We reviewed patients who underwent a surgical resection of a lung adenocarcinoma and were pathologically proven to be T1-2N0M0, from 1999 to 2009. We conducted four different types of analyses (multivariate analysis, receiver operating characteristic [ROC] analysis, survival analysis according to subcategories and survival analysis of propensity score-matched pairs) to evaluate the impacts of GGO and the solid component on recurrence. The study included 241 patients, and there were 34 recurrences. Sixty-eight cases with AIS and minimally invasive adenocarcinoma exhibited 100% recurrence-free survival. A univariate and a multivariate analysis revealed that the maximum tumour diameter measured in the mediastinal window was a better prognostic factor than the maximum tumour diameter in the lung window. This finding was supported by an ROC curve analysis, a subgroup analysis and a propensity score-matched analysis. An ROC curve analysis revealed that GGO component exclusion resulted in improved prognostic performance for recurrence and pathological vessel invasion. A subgroup analysis and a propensity score-matched analysis demonstrated that tumours with similar solid component sizes and different GGO sizes exhibited equivalent recurrence-free survival. The GGO component showed little influence on recurrence. Recurrence-free survival was solely dependent on the solid component size. A T factor measured by the solid component may be a more accurate prognostic parameter.

1 June 2002 in Asian Cardiovascular and Thoracic Annals
Verified
Journal Article
Closed access
PDF file
TMTomohiro Murakawa
Tomohiro Murakawa
JNJun Nakajima
Jun Nakajima
HSHajime Sato
Hajime Sato
MTMakoto Tanaka
Makoto Tanaka
STShinichi Takamoto
Shinichi Takamoto
MFMasashi Fukayama
Masashi Fukayama
As information on the clinical features and prognosis of thymoma complicated by pure red-cell aplasia is limited, follow-up data on thymoma patients who had a thymectomy between 1954 and 1999 were analyzed retrospectively. Six of 166 cases were complicated by pure red-cell aplasia. In 3 of these, the pure red-cell aplasia appeared after surgical intervention. Remission was observed in 2 patients who underwent extended thymectomy. The other 4 patients subsequently died from pure red-cell aplasia. The outcome in patients with pure red-cell aplasia was poorer than that in the entire group of patients with thymoma and in those with thymoma complicated by myasthenia gravis. The possible onset of pure red-cell aplasia after thymectomy should be kept in mind during follow-up.


12 August 2015 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
MKMitsuaki Kawashima
Mitsuaki Kawashima
TMTomohiro Murakawa
Tomohiro Murakawa
TSTomohiro Shinozaki
Tomohiro Shinozaki
JIJunji Ichinose
Junji Ichinose
HHHaruaki Hino
Haruaki Hino
JNJun Nakajima
Jun Nakajima
OBJECTIVES The Glasgow Prognostic Score (GPS), which is calculated with C-reactive protein (CRP) and albumin (Alb) values, is a prognostic indicator for various types of cancers. However, its role in lung cancer still remains unclear, and its optimal cut-off values are controversial. Here, we evaluated the significance of the GPS and adjusted GPS (a-GPS) using our institution's cut-off values in patients undergoing resection for primary lung cancer. METHODS We analysed 1043 lung cancer patients who underwent resection between 1998 and 2012. The overall survival (OS) probabilities of the GPS subgroups were estimated using the Kaplan–Meier method and were compared using the log-rank test. The prognostic significance of the GPS and the a-GPS was assessed by the Cox proportional hazards model with clinicopathological variables and inflammation markers, such as the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR). The GPS was calculated based on cut-off values of 1.0 mg/dl for CRP and 3.5 g/dl for Alb, as previously reported. The a-GPS was calculated based on cut-off values 0.3 mg/dl for CRP and 3.9 g/dl for Alb, which are the standard thresholds used by our institution. RESULTS The GPS and the a-GPS were correlated with preoperative factors, such as age, sex, smoking status, the NLR and the PLR, and oncological factors, including the pathological stage, histological type and level of lymphovascular invasion. The 5-year OS rates were 82, 55 and 55% with GPS 0, 1 and 2 (1 vs 0: P < 0.01; 2 vs 1: P = 0.66), respectively, and 88, 67 and 59% with a-GPS 0, 1 and 2 (1 vs 0: P < 0.01; 2 vs 1: P = 0.04), respectively. Multivariable analysis revealed that the GPS [1 vs 0, hazard ratio (HR): 1.63, 2 vs 0, HR: 1.44] and the a-GPS (1 vs 0, HR: 2.00, 2 vs 0, HR: 2.10) were independent prognostic factors. The a-GPS classification showed a clearer prognostic distribution than the GPS classification. CONCLUSIONS The GPS is a useful prognostic indicator of the OS in lung cancer surgery. The optimal cut-off values for GPS estimation may need to be re-evaluated.

16 February 2017 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
TMTomohiro Murakawa
Tomohiro Murakawa
HSHajime Sato
Hajime Sato
SOSakae Okumura
Sakae Okumura
JNJun Nakajima
Jun Nakajima
HHHirotoshi Horio
Hirotoshi Horio
OJon behalf of the Metastatic Lung Tumor Study Group of Japan
on behalf of the Metastatic Lung Tumor Study Group of Japan
OBJECTIVES: Thoracoscopic surgery for lung metastasectomy remains controversial. The study aimed at determining the efficacy of thoracoscopic surgery for lung metastasectomy. METHODS: This was a multi-institutional, retrospective study that included 1047 patients who underwent lung metastasectomy for colorectal cancer between 1999 and 2014. Prognostic factors of overall survival were compared between the thoracoscopic and open thoracotomy groups using the multivariate Cox proportional hazard model. The propensity score, calculated using the preoperative covariates, included the era of lung surgery as a covariate. A stepwise backward elimination method, with a probability level of 0.15, was used to select the most powerful sets of outcome predictors. The difference between the radiological tumour number and the resected tumour number (delta_num) was also evaluated. RESULTS: The c-statistics and the P-value of the Hosmer–Lemeshow Chi-square of the propensity score model were 0.7149 and 0.1579, respectively. After adjusting for the propensity score, the thoracoscopy group had a better survival rate than the open group (stratified log-rank test: P = 0.0353). After adjusting for the propensity score, the most powerful predictive model for overall survival was that which combined thoracoscopy [hazard ratio (HR): 0.468, 95% CI: 0.262–0.838, P = 0.011] and anatomical resection (HR: 1.49, 95% CI: 1.134–1.953, P = 0.004). Before adjusting for the propensity score, the delta_num was significantly greater in the open group than in the thoracoscopy group (thoracoscopy: 0.06, open: 0.33, P = 0.001); however, after adjustment, there was no difference in the delta_num (thoracoscopy: 0.04, open: 0.19, P = 0.114). CONCLUSIONS: Thoracoscopic metastasectomy showed better overall survival than the open approach in this analysis. The thoracoscopic approach may be an acceptable option for resection of pulmonary metastases in terms of tumour identification and survival outcome in the current era.

18 October 2011 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
MSMiki Sakamoto
Miki Sakamoto
TMTomohiro Murakawa
Tomohiro Murakawa
CKChihiro Konoeda
Chihiro Konoeda
YIYuta Inoue
Yuta Inoue
KKKentaro Kitano
Kentaro Kitano
JNJun Nakajima
Jun Nakajima
Thymoma is a relatively rare tumour and is uniquely associated with autoimmune diseases such as myasthenia gravis (MG). However, the factors involved in the prognosis of thymoma remain under discussion. We retrospectively reviewed 162 patients who underwent extended thymectomy via median sternotomy for thymoma at our institute from 1976 to 2009. The histological subtype was classified according to the World Health Organization (WHO) histological classification system. Survival analysis was performed using the Kaplan–Meier method and the Cox proportional hazards model. Tumours comprised 7 Type A tumours, 38 Type AB, 49 Type B1, 45 Type B2 and 23 Type B3. Various types of autoimmune diseases were comorbid in 66 patients. The median follow-up period was 94 months, and 14 patients experienced recurrence. Seven patients died of recurrent tumour, and 18 patients died of causes other than thymoma. The 10-year overall survival was 85.7%, and the 10-year disease-free survival (DFS) was 76.8%. The 10-year DFS was 62.5% for Type A, 86.3% for Type AB, 91.5% for Type B1, 77.1% for Type B2 and 26.3% for Type B3. In multivariate analysis, age, Type B3 and MG were determined as prognostic factors for survival. On the other hand, Masaoka's stage did not influence survival. Type B3 classified by the WHO histological classification system is a poor prognostic factor for survival of thymoma after extended thymectomy. Association with MG is possibly an indicator of poor survival. Age is an independent prognostic factor, suggesting favourable prognosis of thymoma after surgical treatment. Considering thymoma is a rare tumour, it would be necessary to build a multi-institutional database as soon as possible.